Hospital oncology programs
Cancer and oncology programs within hospital systems that have not yet launched a CAR T-cell therapy program and need a clear path from readiness assessment through implementation.
About acCELLapy
acCELLapy is a specialized healthcare services company that partners with oncology providers, health systems, and biopharma to design, launch, and scale cell therapy programs. We bring together clinical, operational, financial, and quality expertise to help clients build programs that are safe, compliant, financially grounded, and ready to grow.
Why oncology programs need to act now
Cell therapy, and CAR T-cell specifically, has moved from a niche capability available at a limited number of centers since 2017 to a strategic requirement for oncology programs as indications expand and more patients become eligible for treatment.
The question is no longer whether cell therapy will be part of your cancer service line. The question is how quickly and safely you can build a program that delivers these therapies consistently and closer to where patients live.
Today, patient access remains constrained by limited program capacity, fragmented referral pathways, payor contracting complexity, and the difficulty of aligning clinical, financial, and quality requirements into one executable model. acCELLapy was created to help organizations close that gap and prepare for the next wave of advanced therapies.
Who we work with
Independent oncology practices
Independent medical oncology practices evaluating whether and how to offer advanced cell therapy safely, compliantly, and with a sustainable financial model.
Network and MSO oncology organizations
Organizations that use shared SOPs and internal project management as a starting point, and partner with acCELLapy to add specialized clinical, operational, and payor expertise.
Academic medical centers and ATCs
Authorized treatment centers seeking to scale capacity, improve program profitability, optimize throughput, and extend capabilities into affiliated hospital networks.
Biotech and pharma
Biopharma organizations looking to expand market access, support site enablement, and strengthen provider readiness through education, training, and practical implementation support.
The questions we help clients solve
- Will the program be financially sound, and what investments will be required?
- Do we have the capabilities, staffing, infrastructure, and workflows needed to launch?
- What must be in place to operate safely, meet regulatory and quality expectations, and protect patient experience?
- How quickly can we mobilize a program without trying to build everything from scratch?
- How will payer requirements and contracting dynamics affect program performance over time?
How we build programs
Strategy and business case
We assess market opportunity, referral dynamics, expected patient capture, and model economics to support a sustainable launch.
Readiness and capability assessment
We evaluate capabilities across staffing, equipment, workflows, and patient management to define launch readiness and gap-closing priorities.
Program design and implementation
We translate strategy into an implementation roadmap across the full patient journey and site operations.
Clinical, quality, and compliance enablement
We provide implementation-ready building blocks including SOPs, workflows, role clarity, and team training.
Reimbursement and access support
We support cost-per-patient analysis, reimbursement strategy, and payor contracting decisions.
Post-launch support and expansion
We stay engaged after go-live to monitor performance, support new product onboarding, and guide expansion planning.
Why acCELLapy is different
- We build with you, not just advise you: We work elbow to elbow with your teams and bring specialized physicians, nurses, and operators into implementation.
- We start at 80 percent, not zero: We use pre-developed tools and templates so teams spend their time tailoring and validating instead of reinventing.
- We connect strategy to bedside reality: We integrate quality, financial planning, payer strategy, and patient safety into one executable operating model.
- We bring ecosystem optionality: We connect clients to pre-vetted partners to add flexibility and reduce unnecessary build burden.
Vision
All eligible cancer patients should be able to access advanced cell therapy through high-quality programs closer to home.
Mission
Our mission is to prepare oncology organizations for the coming wave of cell therapy by building the capabilities, workflows, and operating models required to expand access safely and improve referral conversion.
Leadership
Leadership profiles will be added once featured experts are finalized.
Placeholder for 3-4 leadership profiles with name, title, short bio, and LinkedIn link.